| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $20.32 ▼ -0.88% | Yesterday | $20.58 ▲ +0.37% | Tomorrow's Aktis Oncology Inc. Common stock (AKTS) setup is anchored to $20.50 and targets $20.32 (-0.88%). The near-term read is downside; watch $21.12 / $19.88 because daily realized volatility is about 4.56%. |
Tomorrow's Aktis Oncology Inc. Common stock (AKTS) setup is anchored to $20.50 and targets $20.32 (-0.88%). The near-term read is downside; watch $21.12 / $19.88 because daily realized volatility is about 4.56%. | ||||
| Week | $19.94 ▼ -2.75% | Last Week | $20.74 ▲ +1.16% | The 7-day Aktis Oncology Inc. Common stock model moves from $20.74 to $19.94 (-2.75%). It gives downside momentum context for this stock, so breaks around $21.12 / $19.88 matter more than a single tick. |
The 7-day Aktis Oncology Inc. Common stock model moves from $20.74 to $19.94 (-2.75%). It gives downside momentum context for this stock, so breaks around $21.12 / $19.88 matter more than a single tick. | ||||
| Month | $19.30 ▼ -5.86% | Last Month | $21.00 ▲ +2.46% | The 1-month Aktis Oncology Inc. Common stock target is $19.30 (-5.86%), compared with the live reference near $20.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Aktis Oncology Inc. Common stock target is $19.30 (-5.86%), compared with the live reference near $20.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $18.34 ▼ -10.51% | Last Year | $21.41 ▲ +4.42% | The 1-year Aktis Oncology Inc. Common stock scenario points to $18.34 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Aktis Oncology Inc. Common stock scenario points to $18.34 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $16.11 ▼ -21.43% | 5 Years Ago | $22.35 ▲ +9.00% | The 5-year Aktis Oncology Inc. Common stock view is $16.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Aktis Oncology Inc. Common stock view is $16.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $20.50 | Mid |
| Daily Change | -1.58% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 60% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $20.50 | Daily Change | -1.58% |
| Market Cap | $1.13B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.